Serum osteoprotegerin is an independent predictor of cardiovascular complications in adults with type 1 diabetes, according to a new analysis from the ongoing Finnish Diabetic Nephropathy (FinnDiane) Study.
Read more
ADA: Serum osteoprotegerin, New Cardiovascular Disease Predictor in TI Diabetes Found
Posted in Medical Research